Guangdong Biolight Meditech Balance Sheet Health
Financial Health criteria checks 5/6
Guangdong Biolight Meditech has a total shareholder equity of CN¥1.4B and total debt of CN¥667.3M, which brings its debt-to-equity ratio to 48.2%. Its total assets and total liabilities are CN¥2.6B and CN¥1.2B respectively. Guangdong Biolight Meditech's EBIT is CN¥1.0M making its interest coverage ratio -0.1. It has cash and short-term investments of CN¥591.8M.
Key information
48.2%
Debt to equity ratio
CN¥667.33m
Debt
| Interest coverage ratio | -0.1x |
| Cash | CN¥591.84m |
| Equity | CN¥1.39b |
| Total liabilities | CN¥1.19b |
| Total assets | CN¥2.58b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300246's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥752.0M).
Long Term Liabilities: 300246's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥437.3M).
Debt to Equity History and Analysis
Debt Level: 300246's net debt to equity ratio (5.4%) is considered satisfactory.
Reducing Debt: 300246's debt to equity ratio has increased from 17.7% to 48.2% over the past 5 years.
Debt Coverage: 300246's debt is well covered by operating cash flow (25.2%).
Interest Coverage: 300246 earns more interest than it pays, so coverage of interest payments is not a concern.